Loading resource…

Mayo Clinic
The article provides a comprehensive review of inclusion body myositis, focusing on its clinical presentation, diagnostic criteria, and management strategies. It highlights the importance of muscle biopsy and emerging diagnostic tools such as cytosolic nucleotidase 1A antibodies and muscle imaging. The article also discusses the limited clinical trial landscape for IBM and the challenges posed by the disease's complex pathophysiology, particularly in the context of aging.
No account needed